Intestinal
mucositis causes great suffering to
cancer patients who undergo
chemotherapy and
radiotherapy. Owing to the uncertain side effects of anticancer drugs to attenuate patients' intestinal
mucositis, many studies focused on
traditional Chinese medicine (TCM).
Patchouli alcohol (PA) is an active compound extracted from Pogostemon cablin, and has potent gastrointestinal protective effect. However, whether PA has an effect on intestinal
mucositis is still unknown. Therefore, we established a rat model of intestinal
mucositis via
intraperitoneal injection of
5-fluorouracil, and intragastrically administrated
PA (10, 20, and 40 mg/kg) to evaluate the effect of PA on intestinal
mucositis. The routine observation (
body weight, food intake, and
diarrhea) in rats was used to detect whether PA had an effect on intestinal
mucositis. Levels of inflammatory
cytokines (TNF-α, IL-1β, IL-6, IL-10, and MPO), mucosal barrier
proteins (zonula occludens -1 (ZO-1),
claudin-1,
occludin,
myosin light chain (MLC), and
mucin-2) and intestinal microbiota were determined to elucidate the underlying mechanism of PA action on intestinal
mucositis in rats. The results showed that PA could effectively improve
body weight, food intake, and
diarrhea in intestinal
mucositis rats, preliminary confirming PA efficacy. Further experiments revealed that PA not only decreased the levels of TNF-α, IL-1β,
IL-6, and MPO but also increased the level of
IL-10 significantly. In addition, the expression of mucosal barrier
proteins and microbiota community were also improved after PA treatment in diseased rats. Hence, PA may prevent the development and progression of intestinal
mucositis by improving
inflammation, protecting mucosal barrier, and regulating intestinal microbiota.